ASH 2013 info

Article

News and updates from the American Society of Hypertension Conference. ASH is the largest organization of hypertension researchers and health care providers in the United States committed to preventing and treating hypertension and its consequences. The editors of ConsultantLive bring you updates from the 2013 ASH conference in San Francisco, CA.

American Society of Hypertension

News and updates from the American Society of Hypertension Conference. ASH is the largest organization of hypertension researchers and health care providers in the United States committed to preventing and treating hypertension and its consequences. The editors of ConsultantLive bring you updates from the 2013 ASH conference in San Francisco, CA.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
Roflumilast Data Showcased Across Diverse Skin Conditions and Age Groups at EADV 2025 / image credit ©molekuul.be/stock.adobe.com

Roflumilast Data Showcased Across Diverse Skin Conditions and Age Groups at EADV 2025

Grace Halsey
September 17th 2025
Article
Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH

Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH

Sydney Jennings
September 17th 2025
Podcast
nt Semaglutide Quells "Food Noise" Among Adults on Treatment for Obesity and Overweight / image credit freshidea/stock.adobe.com

Semaglutide Quells "Food Noise," Improves Mental Health Among Adults on Treatment for Obesity and Overweight

Grace Halsey
September 17th 2025
Article
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Sydney Jennings
September 17th 2025
Podcast
Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late-Stage Trial: Novo Nordisk Update / image credit Timothy Garvey, MD courtesy of University of Alabama at Birmingham

Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late-Stage Trial: Novo Nordisk Update

Grace Halsey
September 17th 2025
Article
Real-Time Continuous Glucose Monitoring Lowers Risk of Large for Gestational Age Infants in Gestational Diabetes / Image credit: ©arturfoto/AdobeStock

Real-Time Continuous Glucose Monitoring Lowers Risk of Large for Gestational Age Infants in Gestational Diabetes

Sydney Jennings
September 17th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.